B7-H3/CD276 and small-cell lung cancer: What's new?
Translational Oncology · 2024-01 · 39 · 101801
DOI: 10.1016/j.tranon.2023.101801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2024-01. Verfasst von Federico Pio Fabrizio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Electronic address: fp.fabrizio@operap…. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Oncology, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Electronic address: fp.fabrizio@operapadrepio.it.
- Laboratory of Oncology, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
- Oncology Centre of Excellence, Therapeutic Science & Strategy Unit, IQVIA, Milan 20019, Italy.
Zitieren
APA
Fabrizio, F. P., Muscarella, L. A., & Rossi, A. (2024). B7-H3/CD276 and small-cell lung cancer: What's new?. Translational Oncology, 39, 101801. https://doi.org/10.1016/j.tranon.2023.101801
Vancouver
Fabrizio FP, Muscarella LA, Rossi A. B7-H3/CD276 and small-cell lung cancer: What's new?. Translational Oncology. 2024;39:101801. doi:10.1016/j.tranon.2023.101801
BibTeX
@article{Fabrizio2024,
author = {Fabrizio, Federico Pio and Muscarella, Lucia Anna and Rossi, Antonio},
title = {B7-H3/CD276 and small-cell lung cancer: What's new?},
journal = {Translational Oncology},
year = {2024},
volume = {39},
pages = {101801},
doi = {10.1016/j.tranon.2023.101801}
}
EUVIMED